Teva Pharmaceutical Industries Ltd. announced a pivotal shift in its business model, revealing that it has officially transitioned from a generics manufacturer to a biopharmaceutical company....
The Investment Committee convened to evaluate the latest performance metrics and future prospects of both Palantir Technologies and QXO during their session on October 10, 2023....
